10
Appendix 1 Jeong et al. A . mPPAR 0 6 12 18 (-) WY Rosi GW CG269 1M 1M 1M Relative reporter activity * * * * * * * B . hPPAR 0 5 10 15 20 (-) WY Rosi GW CG269 1M 1M 1M Relative reporter activity * * * * * * * * 0 2 4 6 8 (-) WY Rosi GW CG269 Relative reporter activity PPAR C . # D . LXR Relative reporter activity 0 2 4 6 8 10 (-) T1317 WY Rosi GW CG269 # E . Relative reporter activity EC 50 = 39 nM PPAR 0 0.0010.01 0.1 1 10 (M) 0 5 10 15 / / / / F . PPAR EC 50 =2.69 M Relative reporter activity (M) 0 0.001 0.01 0.1 1 10 0 5 10 15 / / / / / /

Appendix 1

  • Upload
    walden

  • View
    32

  • Download
    0

Embed Size (px)

DESCRIPTION

A. B. mPPAR a. 18. hPPAR a. **. 20. **. **. **. **. **. 12. Relative reporter activity. 15. Relative reporter activity. 10. *. 6. *. 5. *. 0. (-). WY. Rosi. GW. CG269. 0. 1 m M 1 m M 1 m M. (-). WY. Rosi. GW. CG269. 1 m M 1 m M 1 m M. C. D. #. PPAR d. - PowerPoint PPT Presentation

Citation preview

Appendix 1 Jeong et al.

A.mPPAR

0

6

12

18

(-) WY Rosi GW CG2691M 1M 1M

Rel

ativ

e

rep

ort

er a

ctiv

ity

*

**

****

B.

hPPAR

0

5

10

15

20

(-) WY Rosi GW CG2691M 1M 1M

Rel

ativ

e

rep

ort

er a

ctiv

ity

** ****

**

0

2

4

6

8

(-) WY Rosi GW CG269

Rel

ativ

e

re

po

rter

act

ivit

y

PPARC.

#D.

LXR

Rel

ativ

e

re

po

rter

act

ivit

y

0

2

4

6

8

10

(-) T1317 WY Rosi GW CG269

#

E.

Rel

ativ

e re

po

rter

act

ivit

y EC 50 = 39 nMPPAR

0 0.001 0.01 0.1 1 10(M)

0

5

10

15

//

//F.

PPAR

EC 50 =2.69 M

Rel

ativ

e re

po

rter

act

ivit

y

(M)0 0.001 0.01 0.1 1 10

0

5

10

15

//

////

Appendix 2 Jeong et al.

N

O

F3C

O

N

S

O

HO

OH

OO

O

S

N

Cl

A.

B.

Jeong et al.Appendix 3

*

*

**

B.PPAR

WYGWRosi

Trypsin+

++

++ + + + + +

CG269

+ + + + +

*

*

A.

**

Trypsin

PPARWYGWRosi

++

++

+ + + + + +

CG269

+ + + + +

Jeong et al.Appendix 4

Fo

ld o

f -

oxi

dat

ion

0

0.5

1.0

1.5

(-) WY Rosi CG269

* *

0

2

4

6

8

ACO CPT1Rel

ativ

e g

ene

exp

ress

ion

#

*

#

*

**

**

*

A.

B.

Jeong et al.Appdneix 5

A.

0

2

4

6

8

aP2 Acrp30 LPL CD36Rel

ativ

e g

ene

exp

ress

ion

3T3-L1

#

*

*

*

*

**

*

*#

#

# #*

*

B.

0

2

4

6

8

aP2 Acrp30 LPL CD36

3T3-F442A

Rel

ativ

e g

ene

exp

ress

ion

#

#

**

#

#

**

**

###

* *

Rel

ativ

e m

RN

A PPAR

(-) RosiCG269 (-) RosiCG269 (-) RosiCG2690.0

0.5

1.0

1.5

**

#

*

**

* *

*

*# *# **¶

¶ ¶ ¶

aP2 CD36Acrp30

D.

C.

0

1

2

3

4

aP2 Acrp30 LPL

Rel

ativ

e g

ene

exp

ress

ion

WAT

#*

#

##

*

Veh WYRosi CG269

Jeong et al.Appendix 6

A.

25%

3%

5%

12%9%

4%

42%

Metabolism

oxidation/reduction

Inflammation/immune response

Signaling transduction

Cell growth/division/ apoptosis

Transcription

Others

B.

118

6

15 39

1

Total 246

Rosi

218

CG269

170

85 78

Upregulation Downregulation

100

91 79

C.

CxCl12

Retn

PmvKMthfd1l

Iars

Agpat3

Cfd

Hadhb

Ifi30

Veh CG269 CG269 Rosi 0.5M 5M 1M

1 2 3 4 5 6 7 8

0

2

4

6

8

10

TNF IL-1 IL-6 iNOS MCP1 COX2 MMP9

Rel

ativ

e g

ene

exp

ress

ion

3T3-F442A

*

**

*

*

***

#

#

#

#

#¶¶ ¶

¶ ¶# ¶¶¶ ¶¶¶ ¶

#¶ ¶¶¶¶ ¶ ¶

Jeong et al.Appendix 7

Jeong et al.

Ave

rag

ed

aily

fo

od

inta

ke (

g)

0.0

2.5

5.0

7.5

Veh WY Rosi CG269

Appendix 8

Jeong et al.Appendix 9

Rel

ativ

eg

ene

exp

ress

ion

** *

#

**

*

Jeong et al.Appendix 10

Veh WY Rosi CG269